Concepts (221)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Nephritis, Interstitial | 1 | 2018 | 14 | 0.590 |
Why?
|
| Uveitis | 1 | 2018 | 32 | 0.560 |
Why?
|
| B7-1 Antigen | 6 | 2011 | 73 | 0.520 |
Why?
|
| Vaccinia | 1 | 2012 | 31 | 0.410 |
Why?
|
| Vaccinia virus | 1 | 2012 | 70 | 0.400 |
Why?
|
| Major Histocompatibility Complex | 1 | 2012 | 86 | 0.400 |
Why?
|
| CD4-Positive T-Lymphocytes | 3 | 2012 | 620 | 0.390 |
Why?
|
| Antigens, Viral | 1 | 2012 | 130 | 0.390 |
Why?
|
| Kidney Transplantation | 2 | 2019 | 313 | 0.370 |
Why?
|
| Immunohistochemistry | 5 | 2014 | 847 | 0.350 |
Why?
|
| Peptides | 4 | 2011 | 549 | 0.340 |
Why?
|
| Heart Transplantation | 5 | 2013 | 162 | 0.330 |
Why?
|
| Escherichia coli Infections | 3 | 2014 | 86 | 0.300 |
Why?
|
| Goiter | 1 | 2008 | 9 | 0.300 |
Why?
|
| Thyroid Gland | 1 | 2008 | 79 | 0.280 |
Why?
|
| Racemases and Epimerases | 1 | 2006 | 24 | 0.270 |
Why?
|
| Prostate | 1 | 2006 | 65 | 0.260 |
Why?
|
| Virus Diseases | 2 | 2021 | 114 | 0.250 |
Why?
|
| Graft Rejection | 4 | 2013 | 289 | 0.250 |
Why?
|
| Carcinoma | 1 | 2006 | 115 | 0.250 |
Why?
|
| T-Lymphocytes, Regulatory | 3 | 2013 | 207 | 0.230 |
Why?
|
| Anti-Glomerular Basement Membrane Disease | 1 | 2023 | 8 | 0.220 |
Why?
|
| Glomerulonephritis, Membranous | 1 | 2023 | 14 | 0.220 |
Why?
|
| Enterohemorrhagic Escherichia coli | 2 | 2014 | 13 | 0.220 |
Why?
|
| Mice, Knockout | 10 | 2014 | 1994 | 0.210 |
Why?
|
| Membrane Glycoproteins | 3 | 2011 | 661 | 0.210 |
Why?
|
| Prostatic Neoplasms | 1 | 2006 | 339 | 0.210 |
Why?
|
| Pathologists | 1 | 2022 | 12 | 0.210 |
Why?
|
| Kidney Failure, Chronic | 2 | 2019 | 206 | 0.210 |
Why?
|
| CD28 Antigens | 3 | 2013 | 60 | 0.190 |
Why?
|
| Antigens, CD | 3 | 2011 | 343 | 0.190 |
Why?
|
| Intestinal Mucosa | 2 | 2014 | 225 | 0.190 |
Why?
|
| Lupus Erythematosus, Discoid | 1 | 2021 | 8 | 0.190 |
Why?
|
| Pneumococcal Infections | 1 | 2021 | 35 | 0.180 |
Why?
|
| Lupus Erythematosus, Cutaneous | 1 | 2021 | 13 | 0.180 |
Why?
|
| Streptococcus pneumoniae | 1 | 2021 | 63 | 0.180 |
Why?
|
| Lupus Nephritis | 1 | 2021 | 33 | 0.180 |
Why?
|
| Virulence | 3 | 2021 | 188 | 0.180 |
Why?
|
| Apoptosis Regulatory Proteins | 3 | 2011 | 146 | 0.180 |
Why?
|
| Coinfection | 1 | 2021 | 44 | 0.180 |
Why?
|
| Lymphocyte Activation | 3 | 2012 | 743 | 0.180 |
Why?
|
| Mice | 15 | 2021 | 10292 | 0.170 |
Why?
|
| Thrombospondin 1 | 1 | 2000 | 6 | 0.170 |
Why?
|
| Immunocompromised Host | 1 | 2021 | 100 | 0.170 |
Why?
|
| Mice, Inbred C57BL | 9 | 2014 | 3231 | 0.170 |
Why?
|
| Histidine | 1 | 2000 | 34 | 0.170 |
Why?
|
| CD8-Positive T-Lymphocytes | 3 | 2014 | 648 | 0.160 |
Why?
|
| Host-Pathogen Interactions | 1 | 2021 | 241 | 0.160 |
Why?
|
| Signal Transduction | 5 | 2013 | 2902 | 0.160 |
Why?
|
| Liver Transplantation | 1 | 2021 | 207 | 0.150 |
Why?
|
| Carcinoma, Renal Cell | 1 | 2019 | 83 | 0.150 |
Why?
|
| Kidney Neoplasms | 1 | 2019 | 126 | 0.150 |
Why?
|
| Skin | 1 | 2021 | 357 | 0.150 |
Why?
|
| Gene Expression Profiling | 1 | 2021 | 718 | 0.140 |
Why?
|
| Syndrome | 1 | 2018 | 170 | 0.140 |
Why?
|
| Immunity, Cellular | 1 | 2018 | 171 | 0.140 |
Why?
|
| Autoantibodies | 2 | 2023 | 172 | 0.140 |
Why?
|
| Animals | 16 | 2021 | 19651 | 0.130 |
Why?
|
| T-Lymphocytes | 3 | 2010 | 986 | 0.130 |
Why?
|
| Shiga Toxin | 2 | 2014 | 4 | 0.130 |
Why?
|
| Aging | 1 | 2021 | 710 | 0.120 |
Why?
|
| Th2 Cells | 2 | 2013 | 99 | 0.120 |
Why?
|
| Adoptive Transfer | 2 | 2012 | 147 | 0.120 |
Why?
|
| Obesity | 1 | 2022 | 1166 | 0.120 |
Why?
|
| Receptors, Antigen, T-Cell | 2 | 2014 | 281 | 0.110 |
Why?
|
| Humans | 16 | 2023 | 59360 | 0.110 |
Why?
|
| Glial Fibrillary Acidic Protein | 1 | 2014 | 36 | 0.110 |
Why?
|
| Shiga-Toxigenic Escherichia coli | 1 | 2013 | 7 | 0.110 |
Why?
|
| Central Nervous System Diseases | 1 | 2014 | 56 | 0.110 |
Why?
|
| Communicable Diseases, Emerging | 1 | 2013 | 21 | 0.110 |
Why?
|
| Bleaching Agents | 1 | 2013 | 6 | 0.110 |
Why?
|
| Sodium Hypochlorite | 1 | 2013 | 12 | 0.100 |
Why?
|
| Bone Marrow | 2 | 2011 | 177 | 0.100 |
Why?
|
| Hemolytic-Uremic Syndrome | 1 | 2012 | 7 | 0.100 |
Why?
|
| Citrobacter rodentium | 1 | 2012 | 5 | 0.100 |
Why?
|
| Inhibitory Concentration 50 | 1 | 2012 | 88 | 0.100 |
Why?
|
| Kidney | 2 | 2013 | 416 | 0.100 |
Why?
|
| Cross Reactions | 1 | 2012 | 127 | 0.100 |
Why?
|
| Actins | 1 | 2014 | 259 | 0.100 |
Why?
|
| Renal Insufficiency | 1 | 2013 | 65 | 0.100 |
Why?
|
| Autoimmunity | 1 | 2014 | 223 | 0.100 |
Why?
|
| Antigen-Presenting Cells | 2 | 2011 | 177 | 0.100 |
Why?
|
| Central Nervous System | 1 | 2014 | 193 | 0.100 |
Why?
|
| Interleukin-6 | 1 | 2013 | 310 | 0.090 |
Why?
|
| Growth Inhibitors | 1 | 2011 | 25 | 0.090 |
Why?
|
| Self Tolerance | 1 | 2011 | 19 | 0.090 |
Why?
|
| Homeodomain Proteins | 1 | 2012 | 255 | 0.090 |
Why?
|
| Acute Kidney Injury | 1 | 2013 | 132 | 0.090 |
Why?
|
| Transplantation Tolerance | 1 | 2011 | 65 | 0.090 |
Why?
|
| Glomerulonephritis | 1 | 2011 | 31 | 0.090 |
Why?
|
| Renal Dialysis | 2 | 2013 | 189 | 0.090 |
Why?
|
| Lymphocytic Choriomeningitis | 1 | 2010 | 53 | 0.090 |
Why?
|
| Isoantigens | 1 | 2010 | 71 | 0.080 |
Why?
|
| Endothelium, Vascular | 1 | 2011 | 169 | 0.080 |
Why?
|
| Mice, Inbred BALB C | 4 | 2013 | 868 | 0.080 |
Why?
|
| Solitary Fibrous Tumors | 1 | 2009 | 1 | 0.080 |
Why?
|
| Mouth Neoplasms | 1 | 2009 | 31 | 0.080 |
Why?
|
| Male | 7 | 2023 | 27739 | 0.080 |
Why?
|
| Cytokines | 1 | 2012 | 912 | 0.080 |
Why?
|
| Receptors, Cell Surface | 1 | 2011 | 428 | 0.070 |
Why?
|
| Parathyroid Glands | 1 | 2008 | 8 | 0.070 |
Why?
|
| Thyroidectomy | 1 | 2008 | 31 | 0.070 |
Why?
|
| Female | 8 | 2019 | 30705 | 0.070 |
Why?
|
| Treatment Failure | 1 | 2008 | 185 | 0.070 |
Why?
|
| Membrane Proteins | 1 | 2013 | 850 | 0.070 |
Why?
|
| Amyloid | 1 | 2008 | 65 | 0.070 |
Why?
|
| Antigens, Surface | 1 | 2008 | 192 | 0.070 |
Why?
|
| Nephrosis, Lipoid | 1 | 2006 | 6 | 0.070 |
Why?
|
| B7-H1 Antigen | 3 | 2011 | 54 | 0.060 |
Why?
|
| Adult | 3 | 2019 | 15669 | 0.060 |
Why?
|
| Immunization | 1 | 2006 | 128 | 0.060 |
Why?
|
| Biopsy, Needle | 1 | 2006 | 132 | 0.060 |
Why?
|
| Diabetes Mellitus, Type 1 | 1 | 2011 | 605 | 0.060 |
Why?
|
| Programmed Cell Death 1 Receptor | 3 | 2011 | 56 | 0.060 |
Why?
|
| Ligands | 3 | 2011 | 411 | 0.060 |
Why?
|
| Transplantation, Homologous | 3 | 2011 | 244 | 0.060 |
Why?
|
| Cells, Cultured | 3 | 2014 | 2093 | 0.060 |
Why?
|
| Phospholipases | 1 | 2023 | 9 | 0.050 |
Why?
|
| Receptors, Phospholipase A2 | 1 | 2023 | 2 | 0.050 |
Why?
|
| Toluene | 1 | 2023 | 7 | 0.050 |
Why?
|
| Hematopoietic Stem Cell Transplantation | 1 | 2006 | 328 | 0.050 |
Why?
|
| Cyclophosphamide | 1 | 2023 | 75 | 0.050 |
Why?
|
| Polyesters | 1 | 2023 | 46 | 0.050 |
Why?
|
| Government Agencies | 1 | 2022 | 10 | 0.050 |
Why?
|
| Antibodies, Blocking | 2 | 2013 | 40 | 0.050 |
Why?
|
| Middle Aged | 4 | 2021 | 16317 | 0.050 |
Why?
|
| Protein Binding | 2 | 2011 | 1557 | 0.050 |
Why?
|
| Gene Ontology | 1 | 2021 | 38 | 0.050 |
Why?
|
| Tacrolimus | 1 | 2021 | 62 | 0.050 |
Why?
|
| Gene Expression Regulation | 1 | 2008 | 1552 | 0.040 |
Why?
|
| Disease Susceptibility | 1 | 2021 | 157 | 0.040 |
Why?
|
| Mycophenolic Acid | 1 | 2021 | 67 | 0.040 |
Why?
|
| Orthomyxoviridae Infections | 1 | 2021 | 69 | 0.040 |
Why?
|
| Chemokines | 1 | 2021 | 93 | 0.040 |
Why?
|
| Flow Cytometry | 2 | 2014 | 644 | 0.040 |
Why?
|
| Disease Models, Animal | 2 | 2021 | 2050 | 0.040 |
Why?
|
| Tetrahydrofolate Dehydrogenase | 1 | 2000 | 15 | 0.040 |
Why?
|
| Platelet Activation | 1 | 2000 | 26 | 0.040 |
Why?
|
| Chromatography, Affinity | 1 | 2000 | 48 | 0.040 |
Why?
|
| Influenza A virus | 1 | 2021 | 116 | 0.040 |
Why?
|
| Disulfides | 1 | 2000 | 62 | 0.040 |
Why?
|
| Phylogeny | 1 | 2021 | 337 | 0.040 |
Why?
|
| Cell Adhesion Molecules | 1 | 2000 | 85 | 0.040 |
Why?
|
| Allografts | 1 | 2019 | 44 | 0.040 |
Why?
|
| Thermodynamics | 1 | 2000 | 191 | 0.040 |
Why?
|
| Graft Survival | 2 | 2011 | 290 | 0.040 |
Why?
|
| Microfilament Proteins | 1 | 2000 | 108 | 0.040 |
Why?
|
| Nephrectomy | 1 | 2019 | 66 | 0.040 |
Why?
|
| Blood Platelets | 1 | 2000 | 92 | 0.040 |
Why?
|
| Heparin | 1 | 2000 | 111 | 0.040 |
Why?
|
| Mice, Transgenic | 2 | 2014 | 1206 | 0.040 |
Why?
|
| Substrate Specificity | 1 | 2000 | 333 | 0.040 |
Why?
|
| Immunosuppressive Agents | 1 | 2021 | 365 | 0.040 |
Why?
|
| Blotting, Western | 1 | 2000 | 584 | 0.040 |
Why?
|
| Recombinant Proteins | 1 | 2000 | 689 | 0.040 |
Why?
|
| Binding Sites | 1 | 2000 | 881 | 0.040 |
Why?
|
| Age Factors | 1 | 2021 | 1504 | 0.030 |
Why?
|
| Antibodies, Monoclonal | 2 | 2013 | 839 | 0.030 |
Why?
|
| Amino Acid Sequence | 1 | 2000 | 1554 | 0.030 |
Why?
|
| Calcium | 1 | 2000 | 555 | 0.030 |
Why?
|
| Treatment Outcome | 2 | 2019 | 5284 | 0.030 |
Why?
|
| Mice, Inbred Strains | 1 | 2014 | 179 | 0.030 |
Why?
|
| Young Adult | 1 | 2023 | 4267 | 0.030 |
Why?
|
| Jagged-2 Protein | 1 | 2013 | 2 | 0.030 |
Why?
|
| Astrocytes | 1 | 2014 | 116 | 0.030 |
Why?
|
| Europe | 1 | 2013 | 184 | 0.030 |
Why?
|
| Genome, Bacterial | 1 | 2013 | 61 | 0.030 |
Why?
|
| Spinal Cord | 1 | 2014 | 195 | 0.030 |
Why?
|
| Disease Outbreaks | 1 | 2013 | 102 | 0.030 |
Why?
|
| Injections, Intravenous | 1 | 2013 | 155 | 0.030 |
Why?
|
| Histocompatibility Antigens | 1 | 2013 | 107 | 0.030 |
Why?
|
| HeLa Cells | 1 | 2014 | 526 | 0.030 |
Why?
|
| Mice, Mutant Strains | 1 | 2013 | 297 | 0.030 |
Why?
|
| Bacterial Adhesion | 1 | 2012 | 58 | 0.020 |
Why?
|
| Suicide, Attempted | 1 | 2013 | 105 | 0.020 |
Why?
|
| Interferon-gamma | 1 | 2014 | 551 | 0.020 |
Why?
|
| Recovery of Function | 1 | 2013 | 270 | 0.020 |
Why?
|
| Inbreeding | 1 | 2011 | 5 | 0.020 |
Why?
|
| Signaling Lymphocytic Activation Molecule Family Member 1 | 1 | 2011 | 3 | 0.020 |
Why?
|
| Mice, Congenic | 1 | 2011 | 22 | 0.020 |
Why?
|
| Multiple Sclerosis | 1 | 2014 | 207 | 0.020 |
Why?
|
| Mice, 129 Strain | 1 | 2011 | 37 | 0.020 |
Why?
|
| Immunoenzyme Techniques | 1 | 2011 | 107 | 0.020 |
Why?
|
| Skin Transplantation | 1 | 2011 | 155 | 0.020 |
Why?
|
| Fluorescent Antibody Technique | 1 | 2011 | 217 | 0.020 |
Why?
|
| Lymphocyte Count | 1 | 2010 | 68 | 0.020 |
Why?
|
| Tumor Necrosis Factor Receptor Superfamily, Member 7 | 1 | 2010 | 24 | 0.020 |
Why?
|
| Mice, Inbred CBA | 1 | 2010 | 83 | 0.020 |
Why?
|
| Mice, Inbred DBA | 1 | 2010 | 84 | 0.020 |
Why?
|
| Programmed Cell Death 1 Ligand 2 Protein | 1 | 2009 | 2 | 0.020 |
Why?
|
| Mice, SCID | 1 | 2011 | 513 | 0.020 |
Why?
|
| Leukocyte Common Antigens | 1 | 2009 | 58 | 0.020 |
Why?
|
| Base Sequence | 1 | 2012 | 1302 | 0.020 |
Why?
|
| Mice, Inbred NOD | 1 | 2011 | 516 | 0.020 |
Why?
|
| Genes, MHC Class II | 1 | 2009 | 37 | 0.020 |
Why?
|
| Phosphotransferases (Alcohol Group Acceptor) | 1 | 2009 | 48 | 0.020 |
Why?
|
| Interleukin-2 | 1 | 2010 | 164 | 0.020 |
Why?
|
| Aged | 2 | 2019 | 13416 | 0.020 |
Why?
|
| Hematopoietic Stem Cells | 1 | 2011 | 276 | 0.020 |
Why?
|
| Lupus Erythematosus, Systemic | 1 | 2011 | 158 | 0.020 |
Why?
|
| Autoimmune Diseases | 1 | 2011 | 220 | 0.020 |
Why?
|
| Antigens, CD34 | 1 | 2009 | 54 | 0.020 |
Why?
|
| Forkhead Transcription Factors | 1 | 2009 | 125 | 0.020 |
Why?
|
| TOR Serine-Threonine Kinases | 1 | 2009 | 117 | 0.020 |
Why?
|
| Molecular Sequence Data | 1 | 2012 | 1952 | 0.020 |
Why?
|
| Proto-Oncogene Proteins c-bcl-2 | 1 | 2009 | 98 | 0.020 |
Why?
|
| Transforming Growth Factor beta | 1 | 2009 | 170 | 0.020 |
Why?
|
| Th1 Cells | 1 | 2009 | 174 | 0.020 |
Why?
|
| Proto-Oncogene Proteins c-akt | 1 | 2009 | 188 | 0.020 |
Why?
|
| Histocompatibility Testing | 1 | 2008 | 31 | 0.020 |
Why?
|
| Tissue Donors | 1 | 2008 | 143 | 0.020 |
Why?
|
| Chronic Disease | 1 | 2010 | 716 | 0.020 |
Why?
|
| Histocompatibility Antigens Class II | 1 | 2008 | 182 | 0.020 |
Why?
|
| United States | 1 | 2019 | 7390 | 0.020 |
Why?
|
| Biomarkers, Tumor | 1 | 2009 | 461 | 0.020 |
Why?
|
| Brain | 1 | 2014 | 1488 | 0.020 |
Why?
|
| Carrier Proteins | 1 | 2009 | 697 | 0.010 |
Why?
|
| Lung | 1 | 2009 | 919 | 0.010 |
Why?
|
| Leukemia, Myeloid, Acute | 1 | 2006 | 167 | 0.010 |
Why?
|
| Adolescent | 1 | 2013 | 5824 | 0.010 |
Why?
|
| Aged, 80 and over | 1 | 2009 | 5128 | 0.010 |
Why?
|